| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.09.25 | Xebra Brands Ltd (2): Xebra's 1:10 rollback to be delayed until CTO revoked | 5 | Stockwatch | ||
| 19.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 277 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 19, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025,... ► Artikel lesen | |
| 13.09.25 | Xebra Brands Ltd (2): Xebra Brands to roll back shares one for 10 Sept. 19 | 3 | Stockwatch | ||
| 13.09.25 | Xebra Brands Ltd: Xebra Brands Announces Update on Share Consolidation | 526 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), an international cannabis company, announces that, its previously announced (August 15, 2025)... ► Artikel lesen | |
| XEBRA BRANDS Aktie jetzt für 0€ handeln | |||||
| 04.09.25 | CSE Bulletin: Suspension - XEBRA Brands Ltd. (XBRA) | 372 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 4 septembre/September 2025) - Effective immediately, XEBRA Brands Ltd. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt... ► Artikel lesen | |
| 04.09.25 | Xebra Brands Ltd (2): Xebra Brands suspended by CSE | 3 | Stockwatch | ||
| 04.09.25 | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 296 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 22.08.25 | Xebra Brands Ltd (2): Xebra Brands to be late to file fiscal 2025 results | 1 | Stockwatch | ||
| 22.08.25 | Xebra Brands Ltd: Xebra Brands Announces Issuance of Cease Trade Order | 483 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 22, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (XBRA:CSE)(XBRAF:OTC PINK)(9YC:FSE), a cannabis company, announces that the Company does not expect to... ► Artikel lesen | |
| 16.08.25 | Xebra Brands Ltd: Xebra Brands Announces Share Consolidation and Provides Update on MCTO | 622 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 15, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(FSE:9YC), a international cannabis company, announces that it intends to consolidate its issued and outstanding... ► Artikel lesen | |
| 02.08.25 | Xebra Brands Ltd: Xebra Provides Update on MCTO | 826 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / August 1, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTC PINK:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 16.07.25 | Xebra Brands Ltd: Xebra Provides Update on Management Cease Trade Order | 316 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / July 16, 2025 / Xebra Brands Ltd. ("Xebra") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC), an international cannabis company, is providing an update to its previously disclosed... ► Artikel lesen | |
| 03.07.25 | Xebra Brands Ltd. Terminates Letter of Intent to Acquire BSK Holdings Inc.; Announces Delay in Completion of Annual Filings and MCTO; Announces Loan | 483 | ACCESS Newswire | Continued Partnership to Bring ELEMENTS CBD Product Line to U.S. Market VANCOUVER, BC / ACCESS Newswire / July 2, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0)... ► Artikel lesen | |
| 23.06.25 | Xebra Brands Ltd: Xebra Announces Corporate Update and Correction Notice of Press Release Announcing Grant of Management Cease Trade Order | 468 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. (CSE:XBRA) (the "Company" or "Xebra Brands") announces a correction to the Company's press release dated June 23, 2025 announcing... ► Artikel lesen | |
| 23.06.25 | Xebra Brands Ltd: Xebra Announces Delay in Filing Financial Statements | 345 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / Xebra Brands Ltd. ("Xebra") (XBRA:CSE)(XBRAF:OTCQB)(9YC:FSE), announces today that it was not in a position to file its audited annual financial statements... ► Artikel lesen | |
| 13.05.25 | Xebra Brands Ltd: Xebra Brands Advances Commercialization Efforts with NF Skin | 375 | ACCESS Newswire | Summer 2025 Launch of ELEMENTS CBD Product Line in United States VANCOUVER, BC / ACCESS Newswire / May 13, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading... ► Artikel lesen | |
| 24.04.25 | XFRA 9YC0: WIEDERAUFNAHME/RESUMPTION | 419 | Xetra Newsboard | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| 24.04.25 | Xebra Brands Ltd: Xebra Brands Announces Letter of Intent to Acquire CBD E-Commerce Company BSK Holdings Inc. | 545 | ACCESS Newswire | NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, BC / ACCESS... ► Artikel lesen | |
| 23.04.25 | XFRA 9YC0: AUSSETZUNG/SUSPENSION | 725 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXEBRA BRANDS CL.A... ► Artikel lesen | |
| 15.04.25 | Xebra Brands Ltd: Xebra Brands Executes Manufacturing and Distribution Agreement to Launch CBD Product Line in the U.S. | 449 | ACCESS Newswire | VANCOUVER, BC / ACCESS Newswire / April 15, 2025 / Xebra Brands Ltd. ("Xebra" or the "Company") (CSE:XBRA)(OTCQB:XBRAF)(FSE:9YC0), a leading innovator in the North American cannabis sector, is pleased... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 45,800 | +2,20 % | Bayer: Das wird der zukünftige Top-Seller | Der DAX-Konzern Bayer hat in den zurückliegenden Quartalen mit vielen guten Neuigkeiten aus der Pharma-Sparte bei den Anlegern punkten können. Die Leverkusener befinden sich in einer guten Position... ► Artikel lesen | |
| AURORA CANNABIS | 2,925 | -0,85 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2026 Third Quarter Results | NASDAQ | TSX: ACB
Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 million
... ► Artikel lesen | |
| CANOPY GROWTH | 0,935 | -0,95 % | Canopy Growth: Treffer ohne Gewinn - Trading-Tipp wird zurückgezogen | ||
| TILRAY BRANDS | 6,450 | +0,62 % | Tilray Brands, Inc.: CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet | Die Auszeichnung würdigt CC Pharma als innovativen Marktführer und vertrauenswürdigen Partner auf dem europäischen PharmamarktDENSBORN, Deutschland, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma,... ► Artikel lesen | |
| INNOCAN PHARMA | 4,020 | -3,37 % | INNOCAN PHARMA im Fokus ruhiger Neubewertung | ||
| CRONOS GROUP | 2,252 | +0,63 % | Cronos Group Inc. (CRON): A Bull Case Theory | ||
| SYNBIOTIC | 2,040 | -0,49 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 30,000 | -3,85 % | XFRA ITH0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORAMED PHARMACEUTICALS | 2,564 | -10,97 % | Dividendenbekanntmachungen (16.01.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBVIE INC US00287Y1091 1,73 USD 1,4902 EUR ABBVIE INC CDR CA00288K1084 0,2439 CAD 0,1512 EUR ALAMO GROUP INC US0113111076 0... ► Artikel lesen | |
| OPKO HEALTH | 1,046 | 0,00 % | OPKO Health, Inc.: OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism | This is the third program that successfully combines Entera's oral peptide N-Tab- platform with OPKO's advanced protein chemistry capabilities The companies have accelerated this program and aim... ► Artikel lesen | |
| JAGUAR HEALTH | 0,670 | +13,47 % | Jaguar Health, Inc.: Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi | Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for Mytesi and Canalevia-CA1, which has the potential to provide Jaguar up to an additional... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 3,150 | -0,32 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) | Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,336 | -6,41 % | XORTX Therapeutics Inc.: XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems | CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| TALPHERA | 0,683 | -0,87 % | Talphera, Inc.: Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update | Closed $17 million first tranche financing led by a strategic investment from CorMedix, Inc.
Cash and investments at September 30, 2025 were $21.3 million; combined... ► Artikel lesen |